The role of nicotinic receptor α7 subunits in nicotine discrimination

Neuropharmacology

Volumn 46, Issue 3, 2004, Pages 363-371

  Stolerman, I P ^a   Chamberlain, S ^a   Bizarro, L ^a   Fernandes, C ^a   Schalkwyk, L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Behaviour; Drug discrimination; Genetic modification; Mice; Nicotine; Nicotinic receptors

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ALPHA CHAIN; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; GENOTYPE; KNOCKOUT MOUSE; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; TRAINING; WILD TYPE;

EID: 1242351593     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2003.10.002     Document Type: Article

References (36)

1. Brioni J.D., Kim D.J.B., O'Neill A.B. Nicotine cue: lack of effect of the α7 nicotinic receptor antagonist methyllycaconitine. European Journal of Pharmacology. 301:1996;1-5.
2. Colpaert F.C., Niemegeers C.J.E., Janssen P.A.J. Factors regulating drug cue sensitivity: the effect of training dose in fentanyl-saline discrimination. Neuropharmacology. 19:1980;705-713.
3. Cordero-Erausquin M., Marubio L.M., Klink R., Changeux J.-P. Nicotinic receptor function: new perspectives from knockout mice. Trends in Pharmacological Sciences. 21:2000;211-217.
4. Corringer P.J., Le Novère N., Changeux J.-P. Nicotinic receptors at the amino acid level. Annual Review of Pharmacology and Toxicology. 40:2000;431-458.
5. Damaj M.I., Welch S.P., Martin B.R. In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice. Psychopharmacology. 117:1995;67-73.
6. Damaj M.I., Glassco W., Dukat M., Martin B.R. Pharmacological characterization of nicotine-induced seizures in mice. Journal of Pharmacology and Experimental Therapeutics. 291:1999;1284-1291.
7. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of α 4 and β 2 subunits and is up-regulated by chronic nicotine treatment. Molecular Pharmacology. 41:1992;31-37.
8. Franceschini D., Paylor R., Broide R., Salas R., Bassetto L., Gotti C., De Biasi M. Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures. Brain Research. Molecular Brain Research. 98:2002;29-40.
9. Freeman G.B., Sherman K.A., Gibson G.E. Locomotor activity as a predictor of times and dosages for studies of nicotine's neurochemical actions. Pharmacology, Biochemistry and Behavior. 26:1987;305-312.
10. Gommans J., Stolerman I.P., Shoaib M. Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice. Neuropharmacology. 39:2000;2840-2847.
11. Greenberg I., Kuhn D.M., Appel J.B. Behaviorally induced sensitivity to the discriminable properties of LSD. Psychopharmacologia. 43:1975;229-232.
12. Hirschhorn I.D., Rosecrans J.A. Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine. Psychopharmacologia. 40:1974;109-120.
13. Kita T., Nakashima T., Shirase M., Asahina M., Kurogochi Y. Effects of nicotine on ambulatory activity in mice. Japanese Journal of Pharmacology. 46:1988;141-146.
14. Klink R., d'Exaerde A.D., Zoli M., Changeux J.-P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. Journal of Neuroscience. 21:2001;1452-1463.
15. Kumar R., Reavill C., Stolerman I.P. Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. British Journal of Pharmacology. 90:1987;239-246.
16. Mansbach R.S., Rovetti C.C., Freedland C.S. The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus. Drug and Alcohol Dependence. 52:1998;125-134.
17. Mansvelder H.D., McGehee D.S. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron. 27:2000;349-357.
18. Markou A., Paterson N.E. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine and Tobacco Research. 3:2001;361-373.
19. Mogg A.J., Whiteaker P., McIntosh J.M., Marks M., Collins A.C., Wonnacott S. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII- sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. Journal of Pharmacology and Experimental Therapeutics. 302:2002;197-204.
20. Morrison C.F., Stephenson J.A. Nicotine injections as the conditioned stimulus in discrimination learning. Psychopharmacologia. 15:1969;351-360.
21. Nomikos G.G., Hildebrand B.E., Panagis G., Svensson T.H. Nicotine withdrawal in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroreport. 10:1999;697-702.
22. Orr-Urtreger A., Goldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J.A., Patrick J.W., Beaudet A.L. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. Journal of Neuroscience. 17:1997;9165-9171.
23. Paylor R., Nguyen M., Crawley J.N., Patrick J., Beaudet A., Orr-Urtreger A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal- dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learning and Memory. 5:1998;302-316.
24. Picciotto M.R., Zoli M., Léna C., Bessis A., Lallemand Y., LeNovère N., Vincent P., Pich E.M., Brûlet P., Changeux J.-P. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 374:1995;65-67.
25. Reavill C., Stolerman I.P. Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats. Journal of Psychopharmacology. 1:1987;264-273.
26. 3H](-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology. 27:1988;235-241.
27. Romano C., Goldstein A., Jewell N.P. Characterization of the receptor mediating the nicotine discriminative stimulus. Psychopharmacology. 74:1981;310-315.
28. Schilström B., Svensson H.M., Svensson T.H., Nomikos G.G. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroscience. 85:1998;1005-1009.
29. Shoaib M., Zubaran C., Stolerman I.P. Antagonism of stimulus properties of nicotine by dihydro-β-erythroidine (DHβE) in rats. Psychopharmacology. 149:2000;140-146.
30. Shoaib M., Gommans J., Morley A., Stolerman I.P., Grailhe R., Changeux J.-P. The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology. 42:2002;530-539.
31. Stephens D.N., Mead A.N., Ripley T.L. Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice. Behavioural Pharmacology. 13:2002;327-345.
32. Stolerman I.P., D'Mello G.D. Role of training conditions in discrimination of central nervous system stimulants by rats. Psychopharmacology. 73:1981;295-303.
33. Stolerman I.P., Pratt J.A., Garcha H.S., Giardini V., Kumar R. Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology. 22:1983;1029-1037.
34. Stolerman I.P., Garcha H.S., Pratt J.A., Kumar R. Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology. 84:1984;413-419.
35. Stolerman I.P., Chandler C.J., Garcha H.S., Newton J.M. Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats. Psychopharmacology. 129:1997;390-397.
36. Stolerman I.P., Naylor C., Elmer G.I., Goldberg S.R. Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology. 141:1999;297-306.